verapamil and 2,5-dimethoxybenzenesulfonic acid (1,3-dioxo-2-isoindolyl) ester

verapamil has been researched along with 2,5-dimethoxybenzenesulfonic acid (1,3-dioxo-2-isoindolyl) ester in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ara, T; Arnold, LA; Baranowski, AM; Bikle, DD; Guy, RK; Lynt, WZ; McCallum, MM; Nandhikonda, P; Pearson, D; Yuan, NY	1

Other Studies

1 other study(ies) available for verapamil and 2,5-dimethoxybenzenesulfonic acid (1,3-dioxo-2-isoindolyl) ester

Article	Year
Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Cell Line; High-Throughput Screening Assays; Humans; Indoles; Membranes, Artificial; Methylamines; Nuclear Receptor Coactivator 2; Nuclear Receptor Coactivator 3; Nuclear Receptor Coactivators; Permeability; Protein Binding; Receptors, Calcitriol; Solubility; Structure-Activity Relationship; Transcription, Genetic; TRPV Cation Channels	2012

Article

Year

Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.

Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

Topics: Cell Line; High-Throughput Screening Assays; Humans; Indoles; Membranes, Artificial; Methylamines; Nuclear Receptor Coactivator 2; Nuclear Receptor Coactivator 3; Nuclear Receptor Coactivators; Permeability; Protein Binding; Receptors, Calcitriol; Solubility; Structure-Activity Relationship; Transcription, Genetic; TRPV Cation Channels

2012